Investigators and Programs

Several opportunities for research are available within the Division of Endocrinology. Each of the following investigators is involved in specific fields of research and each may supervise fellows:

Joseph S. Dillon, MD, Clinical studies on therapy of carcinoid and neuroendocrine tumors

Ayotunde Dokun, MD, PhD, How does diabetes interact with genetics and contribute to the poor outcomes in individuals with peripheral arterial disease (PAD)?

Amal Shibli-Rahhal, MD, MS, Clinical studies on bone diseases and medical education

Janet A. Schlechte, MD, Clinical studies on bone and pituitary diseases

William I. Sivitz, MD, Basic studies on mitochondrial metabolism and its role in diabetes and obesity; Clinical studies in the therapy and pathophysiology of diabetes and obesity

Brian O'Neill, MD, PhD, Insulin action on muscle growth and metabolism

Yumi Imai, MD, Mechanisms behind islet dysfunction in diabetes

Mark A. Yorek, PhD, Basic studies in neurovascular complication of diabetes and obesity

There is also active clinical and research participation by faculty in other clinical and basic science departments throughout the university focused on issues that relate directly to endocrinology. Fellows are encouraged to pursue training with these individuals outside of the Division of Endocrinology if that fulfills a critical training goal for the individual. Examples of such faculty include but are not limited to the following:

Basic Mechanisms of Hormone Action

Mario Ascoli, PhD
Deborah L. Segaloff, PhD
Rory Fisher, PhD

Vascular Function in Obesity and Diabetes

Frank Faraci, PhD
Curt Sigmund, PhD

Endocrine Neoplasia

Ronald Weigel, MD, PhD, MBA
James Howe, MD
M. Sue O’Dorisio, MD, PhD

Intensive Insulin Therapies in Children with Type 1 Diabetes

Eva Tsalikian, MD
Michael Tansey, MD

Developmental Origins of Metabolic Disease

Andrew Norris, MD, PhD

Pediatric Endocrinology

Katie M. Larson Ode, MD, MS
Vanessa Curtis, MD